Pletoz 50mg Tablet 10’S

Description

Pletoz 50mg Tablet is a prescription medication that belongs to a class of drugs known as phosphodiesterase type 3 (pde3) inhibitors. it is primarily used to improve symptoms of intermittent claudication, a condition associated with peripheral arterial disease (pad), where reduced blood flow to the limbs—most commonly the legs—causes pain, cramping, or fatigue during walking or physical activity. by improving blood circulation and reducing platelet aggregation, Pletoz 50mg Tablet helps patients walk longer distances with less discomfort and improves overall quality of life in individuals affected by poor peripheral circulation.

the mechanism of action of Pletoz 50mg Tablet is dual in nature. first, it inhibits the pde3 enzyme, leading to an increase in intracellular cyclic adenosine monophosphate (camp). elevated camp levels result in vasodilation, which helps widen blood vessels and improve blood flow, especially in peripheral arteries. second, Pletoz 50mg Tablet exerts an antiplatelet effect by reducing platelet aggregation, which decreases the risk of blood clot formation. this combination of vasodilation and antiplatelet activity makes Pletoz 50mg Tablet particularly effective in improving microcirculation and oxygen delivery to tissues affected by ischemia.

Pletoz 50mg Tablet is typically prescribed for patients with peripheral vascular disease who experience intermittent claudication that limits daily activities such as walking or climbing stairs. it is not a cure for pad but serves as a symptomatic treatment that enhances functional capacity and walking distance. in some clinical situations, it may also be used as part of a broader cardiovascular risk management plan under medical supervision. patients with underlying risk factors such as diabetes, smoking history, hyperlipidemia, or hypertension often benefit from therapies that improve vascular flow, and Pletoz 50mg Tablet plays a supportive role in such management strategies.

unlike simple pain relievers, Pletoz 50mg Tablet works at the vascular and cellular level to improve circulation over time. its therapeutic effects may take several weeks to become noticeable, as it gradually improves blood flow and reduces ischemic symptoms. because of its pharmacological profile, careful patient selection and monitoring are essential to ensure both safety and effectiveness.

ingredients

• Pletoz 50mg Tablet (active ingredient): Pletoz 50mg Tablet is the primary pharmacologically active compound. it works as a selective phosphodiesterase iii inhibitor, increasing intracellular cyclic amp levels in platelets and blood vessels. this leads to inhibition of platelet aggregation and relaxation of vascular smooth muscles, improving blood flow in peripheral arteries and reducing symptoms of claudication.
• microcrystalline cellulose: commonly used as a filler and binder in tablet formulations. it helps maintain tablet structure and ensures consistent drug delivery.
• pregelatinized starch: functions as a disintegrant, helping the tablet break down properly in the digestive system to allow efficient absorption of the active ingredient.
• crospovidone: a superdisintegrant that enhances the breakdown of the tablet in the gastrointestinal tract, ensuring faster and more consistent release of Pletoz 50mg Tablet.
• magnesium stearate: acts as a lubricant during tablet manufacturing to prevent ingredients from sticking to equipment and to ensure uniform tablet formation.
• silicon dioxide: used as an anti-caking agent to maintain powder flow properties during manufacturing and ensure uniform distribution of the active ingredient.

key uses

• management of intermittent claudication associated with peripheral arterial disease, helping patients increase walking distance and reduce leg pain during physical activity.
• improvement of blood circulation in peripheral arteries by promoting vasodilation and reducing vascular resistance in narrowed blood vessels.
• reduction of platelet aggregation, which helps lower the risk of small clot formation that can further restrict blood flow in already narrowed arteries.
• supportive therapy in chronic vascular insufficiency conditions where reduced oxygen delivery to muscles leads to fatigue and discomfort during exertion.
• enhancement of functional mobility and quality of life in patients suffering from lifestyle-limiting symptoms due to poor peripheral circulation.

how to use

Pletoz 50mg Tablet should be used exactly as directed by a qualified healthcare professional. it is typically taken orally in tablet form and is usually administered on an empty stomach, as food may affect its absorption. the medication is generally taken at consistent times each day to maintain stable levels in the bloodstream. patients are advised to follow a regular dosing schedule and avoid skipping doses to ensure maximum therapeutic benefit.

it is important to understand that Pletoz 50mg Tablet does not provide immediate relief of symptoms. improvement in walking distance and reduction in leg pain may take several weeks of continuous use. patients are often advised to combine medication with lifestyle modifications such as regular walking programs, smoking cessation, and dietary improvements to achieve better outcomes in peripheral arterial disease management.

the tablet should be swallowed whole with water and not crushed or chewed unless specifically advised by a healthcare provider. if gastrointestinal discomfort occurs, patients should consult a physician for further guidance rather than altering the dosage on their own.

safety information

• warnings: Pletoz 50mg Tablet should not be used in patients with heart failure of any severity, as pde3 inhibitors have been associated with increased risk of mortality in such individuals. caution is also advised in patients with a history of cardiovascular disease, arrhythmias, or bleeding disorders. regular monitoring may be required during therapy.
• side effects: common side effects include headache, diarrhea, dizziness, abnormal stools, and palpitations. some patients may experience increased heart rate or mild swelling. serious side effects, though rare, may include irregular heartbeat, severe bleeding tendencies, or allergic reactions such as rash, swelling, or difficulty breathing.
• precautions: Pletoz 50mg Tablet should be used cautiously in patients with liver or kidney impairment. it should also be used carefully in individuals taking other medications that affect blood clotting or heart rhythm. elderly patients may be more sensitive to its effects and require closer monitoring.
• pregnancy/breastfeeding: there is limited data regarding the safety of Pletoz 50mg Tablet during pregnancy. it should only be used if clearly needed and prescribed by a healthcare professional. it is not known whether Pletoz 50mg Tablet passes into breast milk, so breastfeeding mothers should consult their doctor before use.
• interactions: Pletoz 50mg Tablet may interact with medications that inhibit cyp3a4 or cyp2c19 enzymes, such as certain antifungals, antibiotics, and proton pump inhibitors, which can increase Pletoz 50mg Tablet levels in the blood. it may also interact with anticoagulants and antiplatelet drugs, increasing the risk of bleeding. alcohol consumption may further increase dizziness or cardiovascular side effects and should be avoided or limited.

additional information

• storage: Pletoz 50mg Tablet should be stored at room temperature away from moisture, heat, and direct sunlight. it should be kept in its original packaging and out of reach of children and pets.
• missed dose: if a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next scheduled dose. in that case, the missed dose should be skipped. patients should not double the dose to make up for a missed one.
• overdose: overdose may lead to severe headache, hypotension, tachycardia, vomiting, or excessive bleeding tendencies. in case of suspected overdose, immediate medical attention is required, and emergency services should be contacted without delay.
• habit forming: Pletoz 50mg Tablet is not habit-forming and does not produce dependency. however, it should still be used strictly under medical supervision due to its cardiovascular effects.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.